"10.1371_journal.pmed.1001606","plos medicine","2014-02-25T00:00:00Z","Krista Fischer; Johannes Kettunen; Peter Würtz; Toomas Haller; Aki S Havulinna; Antti J Kangas; Pasi Soininen; Tõnu Esko; Mari-Liis Tammesoo; Reedik Mägi; Steven Smit; Aarno Palotie; Samuli Ripatti; Veikko Salomaa; Mika Ala-Korpela; Markus Perola; Andres Metspalu","The Estonian Genome Center, University of Tartu, Tartu, Estonia; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland; Computational Medicine, Institute of Health Sciences, University of Oulu and Oulu University Hospital, Oulu, Finland; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America; Division of Genetics, Childrens Hospital, Boston, Massachusetts, United States of America; Division of Endocrinology, Childrens Hospital, Boston, Massachusetts, United States of America; Program in Genomics, Childrens Hospital, Boston, Massachusetts, United States of America; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America; Wellcome Trust Sanger Institute, Hinxton, United Kingdom; Computational Medicine, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom; Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia","¶ These authors are joint senior authors on this work.","PW AJK PS and MAK are shareholders of Brainshake Ltd., a startup company offering NMR-based metabolite profiling. All other authors declare that no competing interests exist.","2014","02","Krista Fischer","KF",17,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
